216 related articles for article (PubMed ID: 35896805)
21. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
22. Anti-U1RNP antibodies are associated with a distinct clinical phenotype and a worse survival in patients with systemic sclerosis.
Chevalier K; Chassagnon G; Leonard-Louis S; Cohen P; Dunogue B; Regent A; Thoreau B; Mouthon L; Chaigne B
J Autoimmun; 2024 Jun; 146():103220. PubMed ID: 38642508
[TBL] [Abstract][Full Text] [Related]
23. Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud's phenomenon in SLE patients.
Furtado RN; Pucinelli ML; Cristo VV; Andrade LE; Sato EI
Lupus; 2002; 11(1):35-41. PubMed ID: 11899953
[TBL] [Abstract][Full Text] [Related]
24. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
26. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
Akiyama Y; Suzuki T; Tanaka M; Kobayashi K; Kagiri T; Ishibashi T; Kitagawa H; Imai F; Hara K; Doi Y
Arerugi; 1990 Jun; 39(6):542-7. PubMed ID: 2222196
[TBL] [Abstract][Full Text] [Related]
27. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study.
Batu ED; Günalp A; Şahin S; Özdel S; Kızıldağ Z; Pac Kısaarslan A; Bağrul İ; Kasap Cuceoglu M; Tanatar A; Sonmez HE; Sag E; Demir S; Çelikel E; Cağlayan S; Çelikel Acar B; Sözeri B; Aktay Ayaz N; Bilginer Y; Poyrazoğlu MH; Ünsal E; Kasapçopur Ö; Özen S
Rheumatol Int; 2023 Aug; 43(8):1485-1495. PubMed ID: 36906866
[TBL] [Abstract][Full Text] [Related]
28. Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.
Calderon J; Rodriguez-Valverde V; Sanchez Andrade S; Riestra JL; Gomez-Reyno J
Clin Rheumatol; 1984 Dec; 3(4):483-92. PubMed ID: 6335422
[TBL] [Abstract][Full Text] [Related]
29. Mixed Connective Tissue Disease as Different Entity: Global Methylation Aspect.
Filipowicz G; Wajda A; Stypińska B; Kmiołek T; Felis-Giemza A; Stańczyk S; Czuszyńska Z; Walczyk M; Olesińska M; Paradowska-Gorycka A
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895173
[TBL] [Abstract][Full Text] [Related]
30. Brief Report: How Do Patients With Newly Diagnosed Systemic Lupus Erythematosus Present? A Multicenter Cohort of Early Systemic Lupus Erythematosus to Inform the Development of New Classification Criteria.
Mosca M; Costenbader KH; Johnson SR; Lorenzoni V; Sebastiani GD; Hoyer BF; Navarra S; Bonfa E; Ramsey-Goldman R; Medina-Rosas J; Piga M; Tani C; Tedeschi SK; Dörner T; Aringer M; Touma Z
Arthritis Rheumatol; 2019 Jan; 71(1):91-98. PubMed ID: 30035365
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of 151 patients with high-titer U1RNP antibodies.
Frandsen PB; Kriegbaum NJ; Ullman S; Høier-Madsen M; Wiik A; Halberg P
Clin Rheumatol; 1996 May; 15(3):254-60. PubMed ID: 8793256
[TBL] [Abstract][Full Text] [Related]
32. Comparison of articular manifestations of mixed connective tissue disease and systemic lupus erythematosus on clinical examination and musculoskeletal ultrasound.
Gunashekar S; Prakash M; Minz RW; Sharma A; Sharma S; Dhir V
Lupus; 2018 Nov; 27(13):2086-2092. PubMed ID: 30304980
[TBL] [Abstract][Full Text] [Related]
33. Clinical and immunologic manifestations of mixed connective tissue disease in a Miami population compared to a Midwestern US Caucasian population.
Maldonado ME; Perez M; Pignac-Kobinger J; Marx ET; Tozman EM; Greidinger EL; Hoffman RW
J Rheumatol; 2008 Mar; 35(3):429-37. PubMed ID: 18260175
[TBL] [Abstract][Full Text] [Related]
34. Can SLE classification rules be effectively applied to diagnose unclear SLE cases?
Mesa A; Fernandez M; Wu W; Narasimhan G; Greidinger EL; Mills DK
Lupus; 2017 Feb; 26(2):150-162. PubMed ID: 27353506
[TBL] [Abstract][Full Text] [Related]
35. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
[TBL] [Abstract][Full Text] [Related]
36. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions.
Kallenberg CG
Curr Opin Rheumatol; 1993 Nov; 5(6):809-15. PubMed ID: 8117544
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
38. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
[TBL] [Abstract][Full Text] [Related]
39. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
Lundberg I; Hedfors E
J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
